Research indicates that elevated ROS concentrations in cancer cells arise from multiple mechanisms: heightened cellular metabolism, mitochondrial dysfunction induced by hypoxia or autophagy, peroxisome activation, dysregulation of growth factor mediated signaling pathways, oncogene activation, and increased activity of ROS-generating enzymes like xanthine oxidase and peroxidases. This evidence concerns the gene XDH and cancer.